Hong Kong stock anomaly | Fosun Pharma (02696.HK) rises more than 7% again, HLX13 completes first patient dosing in clinical study for advanced liver cancer.

According to the Smart Finance and Economics APP, Fuhong Hanlin (02696.HK) has risen by over 7% again, as of the time of publication, it has increased by 7.15%, to 43.45 Hong Kong dollars, with a trading volume of 36.6217 million Hong Kong dollars.